← Back to feed Brand & Business

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Wired 24 April 2026 13h ago
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
62
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
14/15
Depth
2/15
Relevance Freshness Authority Brand Depth
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Read Full Article → Wired ↗